RVMDW vs. SNDK

Last updated Jun 4, 2026

RVMDW (Revolution Medicines Inc. Warrant) and SNDK (Sandisk Corp) are both stocks. RVMDW operates in Biotechnology (Healthcare), while SNDK operates in Computer Hardware (Technology). Over the past year, RVMDW returned 3194.74% vs 4639.91% for SNDK. At a 0.08 correlation, their price movements are largely independent.

Performance

RVMDW vs. SNDK - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Revolution Medicines Inc. Warrant (RVMDW) and Sandisk Corp (SNDK). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, RVMDW achieves a 566.03% return, which is significantly lower than SNDK's 671.55% return.

RVMDW

• 1D: 6.46%
• 1M: 16.79%
• YTD: 566.03%
• 6M: 662.67%
• 1Y: 3,194.74%
• 3Y*: —
• 5Y*: —
• 10Y*: —

SNDK

• 1D: 6.71%
• 1M: 45.84%
• YTD: 671.55%
• 6M: 842.23%
• 1Y: 4,639.91%
• 3Y*: —
• 5Y*: —
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

RVMDW vs. SNDK - Yearly Performance Comparison

	2026 (YTD)	2025
RVMDW Revolution Medicines Inc. Warrant	566.03%	454.51%
SNDK Sandisk Corp	671.55%	388.44%

Correlation

The correlation between RVMDW and SNDK is 0.06, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.06
Correlation (All Time) Calculated using the full available price history since Feb 25, 2025	0.08

Fundamentals

Market Cap RVMDW : $1.24B SNDK : $287.55B
EPS RVMDW : -$7.17 SNDK : $29.70
PB Ratio RVMDW : 0.83 SNDK : 20.87
Total Revenue (TTM) RVMDW : $0.00 SNDK : $13.18B
Gross Profit (TTM) RVMDW : -$4.70M SNDK : $7.39B
EBITDA (TTM) RVMDW : -$1.34B SNDK : $5.37B

Return for Risk

RVMDW vs. SNDK — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

RVMDW

RVMDW Risk / Return Rank: 99
RVMDW Sharpe Ratio Rank: 100
RVMDW Sortino Ratio Rank: 99
RVMDW Omega Ratio Rank: 98
RVMDW Calmar Ratio Rank: 100
RVMDW Martin Ratio Rank: 100

SNDK

SNDK Risk / Return Rank: 100
SNDK Sharpe Ratio Rank: 100
SNDK Sortino Ratio Rank: 99
SNDK Omega Ratio Rank: 99
SNDK Calmar Ratio Rank: 100
SNDK Martin Ratio Rank: 100

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

RVMDW vs. SNDK - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Revolution Medicines Inc. Warrant (RVMDW) and Sandisk Corp (SNDK). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	RVMDW	SNDK	Difference
Sharpe ratio Return per unit of total volatility	13.27	48.18	-34.91
Sortino ratio Return per unit of downside risk	6.03	8.51	-2.47
Omega ratio Gain probability vs. loss probability	1.74	2.19	-0.45
Calmar ratio Return relative to maximum drawdown	54.33	150.40	-96.07
Martin ratio Return relative to average drawdown	116.19	460.18	-343.98
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

RVMDW vs. SNDK - Sharpe Ratio Comparison

The current RVMDW Sharpe Ratio is 13.27, which is lower than the SNDK Sharpe Ratio of 48.18. The chart below compares the historical Sharpe Ratios of RVMDW and SNDK, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	RVMDW	SNDK	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	13.27	48.18	-34.91
Sharpe Ratio (All Time) Calculated using the full available price history	0.34	16.96	-16.62

Drawdowns

RVMDW vs. SNDK - Drawdown Comparison

The maximum RVMDW drawdown since its inception was -96.90%, which is greater than SNDK's maximum drawdown of -47.50%. Use the drawdown chart below to compare losses from any high point for RVMDW and SNDK.

Drawdown Indicators

	RVMDW	SNDK	Difference
Max Drawdown Largest peak-to-trough decline	-96.90%	-47.50%	-49.40%
Max Drawdown (1Y) Largest decline over 1 year	-59.65%	-31.34%	-28.31%
Current Drawdown Current decline from peak	-9.28%	0.00%	-9.28%
Average Drawdown Average peak-to-trough decline	-67.28%	-13.79%	-53.49%
Ulcer Index Depth and duration of drawdowns from previous peaks	27.84%	10.22%	+17.62%

Volatility

RVMDW vs. SNDK - Volatility Comparison

Revolution Medicines Inc. Warrant (RVMDW) has a higher volatility of 29.38% compared to Sandisk Corp (SNDK) at 26.91%. This indicates that RVMDW's price experiences larger fluctuations and is considered to be riskier than SNDK based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	RVMDW	SNDK	Difference
Volatility (1M) Calculated over the trailing 1-month period	29.38%	26.91%	+2.47%
Volatility (6M) Calculated over the trailing 6-month period	151.04%	70.59%	+80.45%
Volatility (1Y) Calculated over the trailing 1-year period	249.45%	97.85%	+151.60%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	314.25%	97.01%	+217.24%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	314.25%	97.01%	+217.24%

Dividends

RVMDW vs. SNDK - Dividend Comparison

Neither RVMDW nor SNDK has paid dividends to shareholders.

Tickers have no history of dividend payments

Financials

Frequently Asked Questions

Can I hold both RVMDW and SNDK in my portfolio?

RVMDW and SNDK have a correlation of 0.06, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, RVMDW or SNDK?

RVMDW has higher volatility (29.38%) compared to SNDK (26.91%). In terms of maximum drawdown, RVMDW dropped -96.90% vs SNDK's -47.50%.

Which has better risk-adjusted returns?

SNDK currently has the higher Sharpe Ratio (48.18 vs 13.27), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.